CD38 in Advanced Prostate Cancers

BACKGROUND: CD38, a druggable ectoenzyme, is involved in the generation of adenosine, which is implicated in tumour immune evasion. Its expression and role in prostate tumour-infiltrating immune cells (TIICs) have not been elucidated. OBJECTIVE: To characterise CD38 expression on prostate cancer (PC...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Urol
Päätekijät: Guo, Christina, Crespo, Mateus, Gurel, Bora, Dolling, David, Rekowski, Jan, Sharp, Adam, Petremolo, Antonella, Sumanasuriya, Semini, Rodrigues, Daniel N., Ferreira, Ana, Pereira, Rita, Figueiredo, Ines, Mehra, Niven, Lambros, Maryou B.K., Neeb, Antje, Gil, Veronica, Seed, George, Terstappen, Leon, Alimonti, Andrea, Drake, Charles G., Yuan, Wei, de Bono, Johann S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier Science 2021
Aiheet:
Platinum Priority – Prostate Cancer
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8175332/
https://ncbi.nlm.nih.gov/pubmed/33678520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2021.01.017
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia